| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Chief Commercial Officer
2 companies
Reiter Sarah serves as a Chief Business Officer at CBUS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $7K at current prices.
The biggest single holding is RKDA (~$7K) as Chief Commercial Officer. Net of sales, the recent Form 4 record there shows accumulation of 3,800 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | RKDA Arcadia Biosciences, Inc. | Chief Commercial Officer | Buy | 700 | $1.72 | $1,204.00 | +22.6% | |
| Dec 23, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Commercial Officer | Buy | 900 | $5.95 | $5,355.00 | +40.9% | |
| Nov 19, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Commercial Officer | Buy | 1,000 | $4.52 | $4,520.00 | +83.3% | |
| Sep 10, 2019 | RKDA Arcadia Biosciences, Inc. | Chief Commercial Officer | Buy | 1,200 | $6.48 | $7,776.00 | New |